Homestead Advisers’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-57,525
| Closed | -$1.79M | – | 136 |
|
|
2022
Q2 | $1.79M | Hold |
57,525
| – | – | 0.05% | 100 |
|
|
2022
Q1 | $2.36M | Hold |
57,525
| – | – | 0.06% | 100 |
|
|
2021
Q4 | $2.5M | Hold |
57,525
| – | – | 0.06% | 101 |
|
|
2021
Q3 | $2.88M | Buy |
57,525
+1,600
| +3% | +$80.1K | 0.07% | 97 |
|
|
2021
Q2 | $3.52M | Hold |
55,925
| – | – | 0.08% | 93 |
|
|
2021
Q1 | $5.2M | Sell |
55,925
-2,700
| -5% | -$251K | 0.12% | 75 |
|
|
2020
Q4 | $5.25M | Sell |
58,625
-4,500
| -7% | -$403K | 0.13% | 73 |
|
|
2020
Q3 | $6.52M | Sell |
63,125
-6,500
| -9% | -$672K | 0.18% | 64 |
|
|
2020
Q2 | $5.51M | Sell |
69,625
-700
| -1% | -$55.4K | 0.14% | 64 |
|
|
2020
Q1 | $4.07M | Sell |
70,325
-1,720
| -2% | -$99.5K | 0.12% | 70 |
|
|
2019
Q4 | $3.89M | Sell |
72,045
-64,299
| -47% | -$3.47M | 0.08% | 84 |
|
|
2019
Q3 | $7.13M | Buy |
136,344
+16,234
| +14% | +$849K | 0.14% | 93 |
|
|
2019
Q2 | $5.8M | Buy |
120,110
+4,676
| +4% | +$226K | 0.11% | 99 |
|
|
2019
Q1 | $5.83M | Buy |
+115,434
| New | +$5.83M | 0.11% | 87 |
|